Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CCSC Technology International A | CCTG | Nov 15, 2024 | 1.51 | -2.58 |
CDT Environmental Technology Investment Holdings | CDTG | Nov 15, 2024 | 3.07 | +14.13 |
CDW | CDW | Nov 15, 2024 | 177.63 | -1.74 |
CEA Industries | CEAD | Nov 15, 2024 | 6.87 | -0.15 |
CECO Environmental | CECO | Nov 15, 2024 | 27.20 | +4.21 |
Cedar Realty Trust B Pref | CDR-B | Nov 15, 2024 | 15.41 | -0.58 |
Cedar Realty Trust C Pref | CDR-C | Nov 15, 2024 | 13.90 | -0.36 |
CEF Income Composite Powershares | PCEF | Nov 15, 2024 | 19.41 | -0.46 |
Cel-Sci | CVM | Nov 15, 2024 | 0.56 | +0.02 |
Celanese | CE | Nov 15, 2024 | 73.78 | -0.22 |
Celcuity | CELC | Nov 15, 2024 | 12.66 | -10.28 |
Celestica | CLS | Nov 15, 2024 | 82.18 | +2.11 |
Celldex Therapeutics | CLDX | Nov 15, 2024 | 23.55 | -8.51 |
Cellebrite | CLBT | Nov 15, 2024 | 17.70 | -1.45 |
Cellectar Biosciences | CLRB | Nov 15, 2024 | 1.86 | -7.46 |
Cellectis ADR | CLLS | Nov 15, 2024 | 1.87 | -2.09 |
Celsius | CELH | Nov 15, 2024 | 25.66 | -4.72 |
Celularity A | CELU | Nov 15, 2024 | 2.46 | +9.33 |
Cementos Pacasmayo ADR | CPAC | Nov 15, 2024 | 6.32 | +0.16 |
CEMEX ADR | CX | Nov 15, 2024 | 5.47 | +2.63 |
Cemtrex | CETX | Nov 15, 2024 | 0.18 | -4.09 |
Cencora | COR | Nov 15, 2024 | 240.24 | -1.30 |
Cenntro | CENN | Nov 15, 2024 | 1.32 | -3.65 |
Cenovus Energy | CVE | Nov 15, 2024 | 15.62 | -1.39 |
Centene | CNC | Nov 15, 2024 | 57.46 | -2.08 |
CenterPoint Energy | CNP | Nov 15, 2024 | 30.86 | +2.94 |
Centerra Gold | CGAU | Nov 15, 2024 | 5.78 | -1.20 |
Centerspace | CSR-C | Nov 15, 2024 | 24.98 | 0.00 |
Centessa Pharmaceuticals ADR | CNTA | Nov 15, 2024 | 16.00 | -8.57 |
Centrais Electricas Brasileiras B ADR | EBR-B | Nov 15, 2024 | 7.07 | +1.58 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.